Benchmark Maintains Buy on Select Medical Hldgs, Raises Price Target to $48
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland maintains a Buy rating on Select Medical Holdings (NYSE:SEM) and raises the price target from $42 to $48.
July 16, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland maintains a Buy rating on Select Medical Holdings and raises the price target from $42 to $48.
The Buy rating and increased price target from a reputable analyst can positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100